Jie Gan
Corporate Officer/Principal en The Hong Kong University of Science & Technology .
Cargos activos de Jie Gan
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
| The Hong Kong University of Science & Technology | Corporate Officer/Principal | - | - |
Historial de carrera de Jie Gan
Antiguos cargos conocidos de Jie Gan.
| Empresas | Cargo | Inicio | Fin |
|---|---|---|---|
China Biologic Products, Inc.
 China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Director/Miembro de la Junta | - | 08/01/2010 |
Formación de Jie Gan.
| Peking University | Graduate Degree |
| Massachusetts Institute of Technology | Doctorate Degree |
| Nanjing University | Undergraduate Degree |
Estadísticas
Internacional
| China | 4 |
| Estados Unidos | 2 |
| Hong-Kong | 2 |
Operativa
| Director/Board Member | 1 |
| Graduate Degree | 1 |
| Doctorate Degree | 1 |
Sectorial
| Consumer Services | 4 |
| Health Technology | 2 |
| Finance | 2 |
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Empresas relacionadas
| Empresas privadas | 1 |
|---|---|
China Biologic Products, Inc.
China Biologic Products, Inc. Pharmaceuticals: MajorHealth Technology China Biologic Products, Inc. operates as a biopharmaceutical company, which engages in the manufacture and distribution of plasma-based pharmaceutical products and other biological substances. Its products include human albumin, human immunoglobulin for intravenous injection, human Hepatitis B immunoglobulin, human rabies immunoglobulin, human immunoglobulin, human coagulation factor VIII, human prothrombin complex concentrate, and placenta polypeptide. The company was founded on December 20, 1989 and is headquartered in Beijing, China. | Health Technology |
- Bolsa de valores
- Insiders
- Jie Gan
- Experiencia
